Diabetes Care:糖尿病首发卒中后死亡危险时间依赖性

2012-06-28 范伟伟译 医学论坛网

  来自德国的一项研究证实,首次卒中后,男性糖尿病患者死亡危险具有时间依赖性。可能的解释在于卒中类型,或者糖尿病患者更早和更强化的危险因素治疗。研究在2012年6月11日在线发表于《糖尿病护理》(Diabetes Care)杂志。   该研究旨在评价糖尿病对患者发生首次卒中事件后死亡率的影响。研究利用一项全国性法定医疗保险基金(Gmünder ErsatzKasse)的理赔数

  来自德国的一项研究证实,首次卒中后,男性糖尿病患者死亡危险具有时间依赖性。可能的解释在于卒中类型,或者糖尿病患者更早和更强化的危险因素治疗。研究在2012年6月11日在线发表于《糖尿病护理》(Diabetes Care)杂志。

  该研究旨在评价糖尿病对患者发生首次卒中事件后死亡率的影响。研究利用一项全国性法定医疗保险基金(Gmünder ErsatzKasse)的理赔数据,纳入了5757例在2005年至2007年发生首次卒中的患者(69.3%为男性,平均年龄68.1岁,32.2%患有糖尿病),评估了该队列至2009年发生的全部死亡。应用Cox回归分析,比较评估糖尿病患者与非糖尿病患者的时间依赖性危险比(HRs)(按性别分层)。

  结果表明,糖尿病男性和女性患者的5年累计死亡率分别为40.0%和54.2%,而在非糖尿病受试者中分别为32.3和38.1%。对于男性受试者,糖尿病患者在最初30天的死亡率显著低于非糖尿病者。约一个季度后,糖尿病患者的风险增加,产生交叉性生存曲线。其后,糖尿病和非糖尿病男性的死亡风险趋于近似。女性受试者的生存曲线型式类似,但是时间依赖性没有统计学意义。年龄增长、出血性卒中、肾功能衰竭(仅适用于男性)、护理依赖程度、处方药的数量与死亡率均显著相关。

     

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1821144, encodeId=3b4d18211440b, content=<a href='/topic/show?id=fc9410131453' target=_blank style='color:#2F92EE;'>#首发卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101314, encryptionId=fc9410131453, topicName=首发卒中)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQHWdlyPWPmuHjfEXicudmC0dJ6SN5PHzglbDHibXpT1VXF2fKDnTzl2Eib4Pf94p58cnSKA3ZfGdFQ/132, createdBy=c44f2500101, createdName=ms2694732865965676, createdTime=Thu Oct 18 12:01:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759149, encodeId=9bf11e5914920, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Aug 29 10:01:00 CST 2012, time=2012-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900958, encodeId=9f5719009589c, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon May 06 04:01:00 CST 2013, time=2013-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671159, encodeId=47e816e115933, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Fri Sep 07 11:01:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636516, encodeId=37f216365164e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Feb 17 15:01:00 CST 2013, time=2013-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442792, encodeId=a1a81442e92b4, content=<a href='/topic/show?id=4198633567d' target=_blank style='color:#2F92EE;'>#死亡危险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63356, encryptionId=4198633567d, topicName=死亡危险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63604994803, createdName=1696533704_45270455, createdTime=Sat Jun 30 05:01:00 CST 2012, time=2012-06-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1821144, encodeId=3b4d18211440b, content=<a href='/topic/show?id=fc9410131453' target=_blank style='color:#2F92EE;'>#首发卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101314, encryptionId=fc9410131453, topicName=首发卒中)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQHWdlyPWPmuHjfEXicudmC0dJ6SN5PHzglbDHibXpT1VXF2fKDnTzl2Eib4Pf94p58cnSKA3ZfGdFQ/132, createdBy=c44f2500101, createdName=ms2694732865965676, createdTime=Thu Oct 18 12:01:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759149, encodeId=9bf11e5914920, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Aug 29 10:01:00 CST 2012, time=2012-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900958, encodeId=9f5719009589c, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon May 06 04:01:00 CST 2013, time=2013-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671159, encodeId=47e816e115933, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Fri Sep 07 11:01:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636516, encodeId=37f216365164e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Feb 17 15:01:00 CST 2013, time=2013-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442792, encodeId=a1a81442e92b4, content=<a href='/topic/show?id=4198633567d' target=_blank style='color:#2F92EE;'>#死亡危险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63356, encryptionId=4198633567d, topicName=死亡危险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63604994803, createdName=1696533704_45270455, createdTime=Sat Jun 30 05:01:00 CST 2012, time=2012-06-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1821144, encodeId=3b4d18211440b, content=<a href='/topic/show?id=fc9410131453' target=_blank style='color:#2F92EE;'>#首发卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101314, encryptionId=fc9410131453, topicName=首发卒中)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQHWdlyPWPmuHjfEXicudmC0dJ6SN5PHzglbDHibXpT1VXF2fKDnTzl2Eib4Pf94p58cnSKA3ZfGdFQ/132, createdBy=c44f2500101, createdName=ms2694732865965676, createdTime=Thu Oct 18 12:01:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759149, encodeId=9bf11e5914920, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Aug 29 10:01:00 CST 2012, time=2012-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900958, encodeId=9f5719009589c, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon May 06 04:01:00 CST 2013, time=2013-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671159, encodeId=47e816e115933, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Fri Sep 07 11:01:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636516, encodeId=37f216365164e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Feb 17 15:01:00 CST 2013, time=2013-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442792, encodeId=a1a81442e92b4, content=<a href='/topic/show?id=4198633567d' target=_blank style='color:#2F92EE;'>#死亡危险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63356, encryptionId=4198633567d, topicName=死亡危险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63604994803, createdName=1696533704_45270455, createdTime=Sat Jun 30 05:01:00 CST 2012, time=2012-06-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1821144, encodeId=3b4d18211440b, content=<a href='/topic/show?id=fc9410131453' target=_blank style='color:#2F92EE;'>#首发卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101314, encryptionId=fc9410131453, topicName=首发卒中)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQHWdlyPWPmuHjfEXicudmC0dJ6SN5PHzglbDHibXpT1VXF2fKDnTzl2Eib4Pf94p58cnSKA3ZfGdFQ/132, createdBy=c44f2500101, createdName=ms2694732865965676, createdTime=Thu Oct 18 12:01:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759149, encodeId=9bf11e5914920, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Aug 29 10:01:00 CST 2012, time=2012-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900958, encodeId=9f5719009589c, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon May 06 04:01:00 CST 2013, time=2013-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671159, encodeId=47e816e115933, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Fri Sep 07 11:01:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636516, encodeId=37f216365164e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Feb 17 15:01:00 CST 2013, time=2013-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442792, encodeId=a1a81442e92b4, content=<a href='/topic/show?id=4198633567d' target=_blank style='color:#2F92EE;'>#死亡危险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63356, encryptionId=4198633567d, topicName=死亡危险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63604994803, createdName=1696533704_45270455, createdTime=Sat Jun 30 05:01:00 CST 2012, time=2012-06-30, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1821144, encodeId=3b4d18211440b, content=<a href='/topic/show?id=fc9410131453' target=_blank style='color:#2F92EE;'>#首发卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101314, encryptionId=fc9410131453, topicName=首发卒中)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQHWdlyPWPmuHjfEXicudmC0dJ6SN5PHzglbDHibXpT1VXF2fKDnTzl2Eib4Pf94p58cnSKA3ZfGdFQ/132, createdBy=c44f2500101, createdName=ms2694732865965676, createdTime=Thu Oct 18 12:01:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759149, encodeId=9bf11e5914920, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Aug 29 10:01:00 CST 2012, time=2012-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900958, encodeId=9f5719009589c, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon May 06 04:01:00 CST 2013, time=2013-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671159, encodeId=47e816e115933, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Fri Sep 07 11:01:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636516, encodeId=37f216365164e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Feb 17 15:01:00 CST 2013, time=2013-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442792, encodeId=a1a81442e92b4, content=<a href='/topic/show?id=4198633567d' target=_blank style='color:#2F92EE;'>#死亡危险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63356, encryptionId=4198633567d, topicName=死亡危险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63604994803, createdName=1696533704_45270455, createdTime=Sat Jun 30 05:01:00 CST 2012, time=2012-06-30, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1821144, encodeId=3b4d18211440b, content=<a href='/topic/show?id=fc9410131453' target=_blank style='color:#2F92EE;'>#首发卒中#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=101314, encryptionId=fc9410131453, topicName=首发卒中)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTKQHWdlyPWPmuHjfEXicudmC0dJ6SN5PHzglbDHibXpT1VXF2fKDnTzl2Eib4Pf94p58cnSKA3ZfGdFQ/132, createdBy=c44f2500101, createdName=ms2694732865965676, createdTime=Thu Oct 18 12:01:00 CST 2012, time=2012-10-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1759149, encodeId=9bf11e5914920, content=<a href='/topic/show?id=9bea33520d' target=_blank style='color:#2F92EE;'>#BET#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=22, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3352, encryptionId=9bea33520d, topicName=BET)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=9a1a37427546, createdName=ms5439512287675881, createdTime=Wed Aug 29 10:01:00 CST 2012, time=2012-08-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1900958, encodeId=9f5719009589c, content=<a href='/topic/show?id=c097591ed5' target=_blank style='color:#2F92EE;'>#Diabetes#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=27, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5917, encryptionId=c097591ed5, topicName=Diabetes)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0045169, createdName=木头人513, createdTime=Mon May 06 04:01:00 CST 2013, time=2013-05-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1671159, encodeId=47e816e115933, content=<a href='/topic/show?id=9f4e360191a' target=_blank style='color:#2F92EE;'>#卒中后#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=36019, encryptionId=9f4e360191a, topicName=卒中后)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ff7426824786, createdName=waiwai3039, createdTime=Fri Sep 07 11:01:00 CST 2012, time=2012-09-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1636516, encodeId=37f216365164e, content=<a href='/topic/show?id=afda591646' target=_blank style='color:#2F92EE;'>#DIA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=24, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5916, encryptionId=afda591646, topicName=DIA)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=987022654425, createdName=ms9608593228839890, createdTime=Sun Feb 17 15:01:00 CST 2013, time=2013-02-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1442792, encodeId=a1a81442e92b4, content=<a href='/topic/show?id=4198633567d' target=_blank style='color:#2F92EE;'>#死亡危险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63356, encryptionId=4198633567d, topicName=死亡危险)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=63604994803, createdName=1696533704_45270455, createdTime=Sat Jun 30 05:01:00 CST 2012, time=2012-06-30, status=1, ipAttribution=)]

相关资讯

美国糖尿病协会(ADA)糖尿病诊疗标准(2012)版中文

  糖尿病是一种慢性疾病,需要持续的治疗、不断的患者自我管理教育和预防急性并发症及降低长期并发症的风险。糖尿病治疗是复杂的,需要解决控制血糖之外的很多问题。大量的证据支持,一定的干预措施可改善糖尿病的结果。   本标准由糖尿病治疗、治疗目标和治疗质量评估工具组成,与临床医生、患者、研究人员、付款人和其他感兴趣的人分享,其中,各项指标适用于大多数糖尿病患者,但须根据患者的个体偏好、合并症以及其他因

糖尿病患者生命质量量表效度好

  首都医科大学附属北京佑安医院生物医学信息中心、昆明医学院第一附属医院、广东医学院人文与管理学院和昆明医学院公共卫生学院对慢性病患者生命质量量表系列-糖尿病量表(QLICD-DM)测试版进行了联合评价。结果发现,所研制的慢性病患者糖尿病生命质量量表具有较好信度、效度和反应度,可作为国内糖尿病患者生命质量测评工具。 相关研究发表于2012年第5期《中国公共卫生》杂志。   研究者们收集

糖尿病患者社区综合干预效果好

  昆明市疾病预防控制中心慢病科张茂镕、田荣等分析评价了社区综合干预措施对糖尿病患者认知水平和病情控制的影响。结果发现,社区综合干预可明显提高糖尿病患者对糖尿病防治知识的认知水平,改善糖尿病患者血糖、血压控制水平。相关研究发表于2012年第5期《中国公共卫生》杂志。   研究者们在云南省昆明市科兴社区选择216例糖尿病患者进行问卷调查和体检,对全部患者进行为期1年半的综合干预并评价干预效果。

Diabetes Care:低羟基维生素D状态或示葡萄糖稳态恶化

  来自丹麦哥本哈根大学的一项研究证实,在校正混杂因素后,血清低25-羟维生素D [25(OH)D]水平与糖尿病的发病风险不存在显著相关关系。然而,低25(OH)D水平与葡萄糖稳态连续标志物的不良纵向变化相关,表明低维生素D状态可能与葡萄糖稳态恶化相关。研究在2012年6月11日在线发表于《糖尿病护理》(Diabetes Care)杂志。   该研究旨在评价维生素D水平是否构

糖尿病的“三五防糖法”

向红丁教授    第3届中国慢病管理大会专门设立了“高危人群管理和自我管理与心、脑、三高一松防治论坛”。在该论坛上,心脑血管疾病、糖尿病、高血压和骨质疏松症等多个领域的专家探讨了自己对慢病管理的认识。同时,论坛还邀请了来自社区的卫生服务人员对慢病管理在社区开展的情况谈谈自身感受。我们选取了其中的精要内容进行整理,希望能帮助全科医生更好地开展社区慢病管理工作。   五个要点   预防